Switch to:
GuruFocus has detected 3 Warning Signs with Biomarin Pharmaceutical Inc $BMRN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Biomarin Pharmaceutical Inc (NAS:BMRN)
Accounts Payable
{IF BankInsurance_zone 1}
$355 Mil (As of )Sep. 2016)
{IF AP_Q_zone 1}{ELSE} {/IF}

Biomarin Pharmaceutical Incs quarterly accounts payable declined from Mar. 2016 ($388 Mil) to Jun. 2016 ($388 Mil) but then increased from Jun. 2016 ($340 Mil) to Sep. 2016 ($355 Mil)

Biomarin Pharmaceutical Incs quarterly accounts payable increased from Dec. 2013 ($183 Mil) to Dec. 2014 ($183 Mil) and increased from Dec. 2014 ($236 Mil) to Dec. 2015 ($445 Mil)


Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Historical Data


Biomarin Pharmaceutical Inc Annual Data

Accts Payable 294859778194147183236445
{IF COMPANY->report_frequency 3M}

{COMPANY->company} Quarterly Data


{COMPANY->company} Semi-Annual Data

Accts Payable 167207236230348390445388340355

Accounts Payable does not apply to insurance companies.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)